People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Enveda Therapeutics, Inc. | — | Biotechnology | Series C | $67.5M | $1.1B | 2022 |
Daniel Wee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Wee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rohit Sharma | 1 | 10 |
| Zavain Dar | 1 | 3 |
| Bruce Beutel | 1 | 1 |
| Shaquille Vayda | 1 | 1 |
| Viswa Colluru | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.